scispace - formally typeset
Z

Zhongchan Sun

Researcher at National Institutes of Health

Publications -  12
Citations -  308

Zhongchan Sun is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 6 publications receiving 269 citations. Previous affiliations of Zhongchan Sun include Fourth Military Medical University.

Papers
More filters
Journal ArticleDOI

Histone deacetylase inhibitors are neuroprotective and preserve NGF-mediated cell survival following traumatic brain injury.

TL;DR: The preservation of sufficient expression of nerve growth factor (NGF) and activation of the neurotrophic tyrosine kinase receptor type 1 (TrkA) pathway following HDACi treatment to be crucial in stimulating the survival of CNS cells after TBI is demonstrated.
Journal ArticleDOI

In Vivo Labeling of Serum Albumin for PET

TL;DR: The distribution and local accumulation of serum albumin can be noninvasively visualized and quantified by 18F-AlF-NEB and 64Cu- NEB PET and the simple labeling and broad applications make these imaging probes attractive for clinical translation.
Journal ArticleDOI

VEGF-loaded graphene oxide as theranostics for multi-modality imaging-monitored targeting therapeutic angiogenesis of ischemic muscle.

TL;DR: The design and synthesis of multifunctional VEGF-loaded IR800-conjugated graphene oxide (GO-IR800-VEGF) for multi-modality imaging-monitored therapeutic angiogenesis of ischemic muscle suggests the great promise of using graphene oxide in theranostic applications for treating isChemic disease.
Journal ArticleDOI

Comparison of three dimeric 18F-AlF-NOTA-RGD tracers.

TL;DR: In this paper, a rapid one-step radiolabeling strategy by the complexation of 18F-aluminum fluoride with NOTA-peptide conjugates was successfully applied to synthesize three dimeric RGD peptides.
Journal ArticleDOI

Development of a New Thiol Site-Specific Prosthetic Group and Its Conjugation with [Cys(40)]-exendin-4 for in Vivo Targeting of Insulinomas

TL;DR: Positron emission tomography results showed that the new thiol-specific tracer, N-5-[(18)F]FPenM-[cys(40)]-exendin-4, had high tumor uptake and rapid liver and kidney clearance, which was comparable to the imaging results with [(18]F]FBEM-[ cys( 40)]- exend in-4 reported by the group.